Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis
Clinical trial NCT03584724 · COMPLETED
Trial details
- NCT number
- NCT03584724
- Sponsor
- Eye Pharma
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2020-08-20
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.